Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
Clinical trial NCT04240704 · TERMINATED
Trial details
- NCT number
- NCT04240704
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2024-09-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.